CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Background Adaptive cellular therapy (ACT), particularly chimeric antigen receptor (CAR)-T cell therapy, has been successful in the treatment of hemopoietic malignancies. However, poor trafficking of administered effector T cells to the tumor poses a great hurdle for this otherwise powerful therapeu...
Saved in:
Main Authors: | Yi Sun, Eduardo Davila, YuJie Guo, Richard D Schulick, Elliott Yee, Yuki Fujiwara, Kaitlyn Dickinson, Zhiwei Sun, Junyi Hu, Yuwen Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e010554.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
by: Xia Liu, et al.
Published: (2022-10-01) -
Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer
by: Lulu Zhang, et al.
Published: (2025-02-01) -
Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation
by: Asiel Arce-Sillas, et al.
Published: (2016-01-01) -
The Alpha-Melanocyte Stimulating Hormone Induces Conversion of Effector T Cells into Treg Cells
by: Andrew W. Taylor, et al.
Published: (2011-01-01) -
T Cell Activation and Regulation of HIV-1: Same Effectors with Distinct Outcomes
by: Jean-François Fortin, et al.
Published: (1999-01-01)